GCM Grosvenor (NASDAQ:GCMG) Stock

GCM Grosvenor

GCM Grosvenor Inc is a world-wide alternative asset management firm. It invests on behalf of clients who seek allocations to alternative investments, such as private equity, infrastructure, real estate, credit, ESG and absolute return strategies. Company invest maximum in Private Equity. The company's offerings include multi-manager portfolios as well as portfolios of direct investments and co-investments.

wall street shutter6

Equities

Government

Large Cap

Macro Economic Events

Regulations

Commodities

Econ #s

Economics

Tech

ETFs

$BTC

AIOT

CENX

SPDR Dow Jones Industrial Average ETF Trust

GCMG

INCY

KALU

MNDY

NVDA

ROIV

STLD

Select Sector SPDR-Consumer Discretionary

Wall Street bounced back on Monday, recovering from Friday&#39;s robust decline fueled by tariff concerns, as investors remained focused on strong earnings from the fourth-quarter reporting season while awaiting further clarity on trade policie

Tech Stocks Surge, Steelmakers Jump On Trump&#39;s 25% Tariffs, Copper Hits 9-Month Highs: What&#39;s Driving Markets Monday?

Analysts

Upgrades

Price Target

Markets

Analyst Ratings

Trading Ideas

ACRS

This Weyerhaeuser Analyst Turns Bullish; Here Are Top 4 Upgrades For Monday

Howard Lutnick

News

Politics

TSLA

Trump&#39;s Commerce Secretary Pick Howard Lutnick&#39;s Fund Owns $1.19B In Nvidia, $804M In Tesla: Here Is A Look At His Portfolio

GCM Grosvenor Inc. - Class A Common Stock

GCM Grosvenor Inc

Pebblebrook Hotel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEB#NYSE">PEB</a>) is looking for FY2025 FFO of $1.50-$1.62 vs $1.61 analyst estimate..

Guidance

Pebblebrook Hotel Sees FY2025 FFO $1.50-$1.62 vs $1.61 Est

Pebblebrook Hotel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEB#NYSE">PEB</a>) is looking for Q1 FFO of $0.09-$0.13 vs $0.15 analyst estimate..

Pebblebrook Hotel Sees Q1 FFO $0.09-$0.13 vs $0.15 Est

Mirum Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIRM#NASDAQ">MIRM</a>) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.28) by 75 percent. This is a 25.76 percent increase over losses of $(0.66) per share from the same period last year. The company reported quarterly sales of $99.430 million which beat the analyst consensus estimate of $96.606 million by 2.92 percent. This is a 42.95 percent increase over sales of $69.554 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

MIRM

Mirum Pharmaceuticals Q4 2024 GAAP EPS $(0.49) Misses $(0.28) Estimate, Sales $99.430M Beat $96.606M Estimate

The Board of Directors of Turning Point Brands, Inc. ("TPB") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPB#NYSE">TPB</a>), a manufacturer, marketer and distributor of branded consumer products including alternative smoking accessories and consumables with active ingredients, declared a regular quarterly dividend of $0.075 per common share. This is a 7% increase over the regular quarter dividend declared in November 2024. The dividend is payable on April 11, 2025, to shareholders of record on the close of business on March 21, 2025.

Dividends

Turning Point Brands Increases Quarterly Dividend From $0.07 To $0.075 Per Share

Schrodinger (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDGR#NASDAQ">SDGR</a>) sees FY2025 sales of $243.402 million-$257.420 million vs $265.80 million analyst estimate.

SDGR

Schrodinger Sees FY2025 Sales $243.402M-$257.420M vs $265.80M Est

Management

VSEC

VSE Appointed Ben Thomas As COO

Schrodinger (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDGR#NASDAQ">SDGR</a>) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.42) by 42.86 percent. This is a 25 percent increase over losses of $(0.32) per share from the same period last year. The company reported quarterly sales of $88.30 million which beat the analyst consensus estimate of $83.20 million by 6.13 percent. This is a 19.12 percent increase over sales of $74.13 million the same period last year.

Schrodinger Q4 Adj $(0.24) Beats $(0.42) Estimate, Sales $88.30M Beat $83.20M Estimate

SGLY

Singularity Future Technology Says On Feb. 20 Ying Cao Resigned From CFO Position, Board Appointed Chee Jiong Ng As CFO

Enterprise artificial intelligence company C3.ai Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AI#NYSE">AI</a>) reported third-quarter financial results after <a href="https://www.benzinga.com/earnings">market close Wednesday.</a>
Here are the key highlights.
What Happened: C3.ai reported third-quarter revenue of $98.8 million, up 26% year-over-year. The revenue total beat a Street consensus estimate of $98.1 million, according to data<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022625&amp;t=be2bearmibe3na1"> from Benzinga Pro.</a>
Subscription revenue totaled $85.7 million in the quarter, up 22% year-over-year. Subscription revenue represented 87% of the company's quarterly total.
The company had a non-GAAP net loss of 12 cents per share, which beat a street consensus estimate of a loss of 25 cents per share.
"In the third quarter, C3.ai achieved significant milestones — expanding our global distribution network, advancing our leadership in agentic and generative AI, and delivering total revenue reaching $98.8 million, up 26% year-over-year," C3.ai CEO Thomas Siebel said.
The company expanded strategic partnerships with Microsoft, AWS and McKinsey Quantumblack in the third quarter.
During the third quarter, C3.ai closed 66 agreements including 50 pilots, an increase of 72% year-over-year. The company closed 21 state and local government agreements. During the third quarter, the company also entered into new and expanded agreements with the U.S. Air Force, U.S. Navy and U.S. Department of Defense.
C3.ai and Microsoft have closed 28 agreements across nine industries as part of its strategic alliance. The joint qualified opportunity pipeline between the two companies was up 244% year-over-year in the quarter.
C3.ai finished the third quarter with $724.3 million in cash and cash equivalents.
Read Also:<a href="https://www.benzinga.com/insights/options/25/01/43196964/c3-ais-options-a-look-at-what-the-big-money-is-thinking"> C3.ai&#8217;s Options: A Look at What the Big Money is Thinking</a>
What's Next: C3.ai will hold its C3 Transform 2025 conference from March 18-20, 2025. The event will include the participation of C3's executive team, customers, partners and sales prospects.
"By bringing together C3.ai experts and early adopters who can speak to the value of Enterprise AI, C3 Transform gives customers, partners and prospects the chance to discover exactly how they can use Enterprise AI and generative AI securely and effectively," the company said.
C3.ai is guiding for fourth-quarter revenue to be in a range of $103.6 million to $113.6 million. Full fiscal year revenue is guided to a range of $383.9 million to $393.9 million.
"We have the technology, the management team, and the global partner ecosystem — through our dramatically expanded strategic partnerships with Microsoft, AWS, and McKinsey QuantumBlack — we believe we have all the elements in place to indelibly change the face of Enterprise AI," Siebel said.
AI Price Action: C3.ai stock is down 1.74% to $25.98 in after-hours trading versus a 52-week trading range of $18.85 to $45.08.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/contracts/25/01/43128646/c3-ai-teams-up-with-mckinsey-for-ai-driven-business-transformations-details">C3.ai Teams Up With McKinsey For AI-Driven Business Transformations: Details</a></li>
</ul>
Photo: Shutterstock

After-Hours Center

Movers

C3.ai Q3 Earnings Highlights: Revenue Beat, EPS Beat, 'Significant Milestones' Achieved

Pebblebrook Hotel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEB#NYSE">PEB</a>) reported quarterly earnings of $0.20 per share which beat the analyst consensus estimate of $0.12 by 66.67 percent. This is a 4.76 percent decrease over earnings of $0.21 per share from the same period last year. The company reported quarterly sales of $337.60 million which beat the analyst consensus estimate of $330.58 million by 2.12 percent. This is a 1.05 percent increase over sales of $334.09 million the same period last year.

Pebblebrook Hotel Q4 FFO $0.20 Beats $0.12 Estimate, Sales $337.60M Beat $330.58M Estimate

Service Properties Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVC#NASDAQ">SVC</a>) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.16 by 6.25 percent. This is a 45.16 percent decrease over earnings of $0.31 per share from the same period last year. The company reported quarterly sales of $456.56 million which beat the analyst consensus estimate of $443.61 million by 2.92 percent. This is a 2.82 percent increase over sales of $444.05 million the same period last year.

Service Properties Trust Q4 FFO $0.17 Beats $0.16 Estimate, Sales $456.56M Beat $443.61M Estimate

WIIM

KNTK

Kinetik shares are trading lower after the company reported worse-than-expected FY24 EPS results.

Biotech

Events

General

AGEN

Agenus Reports Impact Of Immuno-Oncology Data

FS KKR Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSK#NYSE">FSK</a>) reported quarterly earnings of $0.66 per share which missed the analyst consensus estimate of $0.67 by 1.49 percent. This is a 12 percent decrease over earnings of $0.75 per share from the same period last year. The company reported quarterly sales of $407.00 million which missed the analyst consensus estimate of $418.92 million by 2.84 percent. This is a 8.95 percent decrease over sales of $447.00 million the same period last year.

FS KKR Capital Q4 Adj $0.66 Misses $0.67 Estimate, Sales $407.00M Miss $418.92M Estimate

Kinetik Sees FY25 Adjusted EBITDA $1.09B-$1.15B.

TFIN

Triumph Financial Has Agreed To Acquire Greenscreens.ai., Terms Not Disclosed

CCIF

Carlyle Credit Income Fund Shares of Beneficial Interest Q4 EPS $0.57 Up From $(1.92) YoY; Revenue 1.032B Up From $926.2M YoY

Sun Communities Sees Q1 2025 FFO $0.78-$0.86 Vs $1.28 Estimate; Sees FY25 FFO $4.81-$5.05 Vs $7.07 Estimate

Buybacks

ERII

Energy Recovery Announces New $30M Share Repurchase Program

HBNC

Horizon Bancorp Announces Craig Dwight, Chairman of Board, Will Retire On May 1, 2025 And Elects Eric Blackhurst To Serve As An Independent Chairperson, Effective May 1, 2025

Press Releases

CION Investments and GCM Grosvenor Announce SEC Effectiveness of the CION Grosvenor Infrastructure Fund

Financing

AGT Food and Ingredients Inc. Announces Sale of Shortline Rail and Bulk Handling Infrastructure; Partnership with GCM Grosvenor and Mobil Grain Ltd.

GCM Grosvenor Elevate Fund Holds Final Close at Nearly $800 Million, the Largest Debut Private Equity Seeding Fund of Its Kind, Signaling Strong Continued Support for Small and Emerging Firm Founders

GCM Grosvenor to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Investor Conference Call on February 10, 2025

GCM Grosvenor to Present at the UBS Financial Services Conference on February 11, 2025

CION Investments and GCM Grosvenor Announce Launch of the CION Grosvenor Infrastructure Fund with $240 Million Invested in Infrastructure Assets

GCM Grosvenor to Present at the Bank of America Securities Financial Services Conference on February 12, 2025

GCM Grosvenor Expands Insurance Solutions Group with the Hire of Joe Metzger as Managing Director

GCM Grosvenor Reports Fourth Quarter and Full Year 2024 Earnings Results, with 2024 Fundraising Increasing 41%, and Year-to-Date GAAP Net Income, Fee-Related Earnings and Adjusted Net Income Increasing 46%, 19% and 36%, Respectively, Year-Over-Year

GCM Grosvenor Announces Final Close of GCM Grosvenor Co-Investment Opportunities Fund III, Raising Nearly $615 Million

Comments

GCM Grosvenor

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga